HEDS is part of the School of Health and Related Research (ScHARR) at the University of Sheffield. We undertake research, teaching, training and consultancy on all aspects of health related decision science, with a particular emphasis on health economics, HTA and evidence synthesis.

Monday 30 June 2014

Cochrane Collaboration update

New and updated Cochrane Reviews highlighted on their website are:
  • Trastuzumab-containing regimens for metastatic breast cancer
  • Intravenous magnesium sulfate for treating adults with acute asthma in the emergency department
  • Levothyroxine or minimally invasive therapies for benign thyroid nodules
  • Powered versus manual toothbrushing for oral health
  • Oral misoprostol for induction of labour
  • Antimicrobial drugs for treating cholera
  • Vaginal prostaglandin (PGE2 and PGF2a) for induction of labour at term
  • Frequency of administration of erythropoiesis-stimulating agents for the anaemia of end-stage kidney disease in dialysis patients
  • Thermal insulation for preventing inadvertent perioperative hypothermia
  • Plasma and cerebrospinal fluid amyloid beta for the diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI)
  • Bispectral index for improving anaesthetic delivery and postoperative recovery
  • Sumatriptan (all routes of administration) for acute migraine attacks in adults - overview of Cochrane reviews
Posted by at
Labels: